Celldex Therapeutics, Inc. — Director's Dealing 2018

Jun 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2018-06-13

Reporting Person: McMahon Gerald PhD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-13	Non-Qualified Stock Option (right to buy)	$.6011	A	67000	Acquired	2028-06-13	Common Stock (67000)	Direct

Footnotes

F1: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.